Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Targeted Pathway Inhibition in Patients With Pancreatic Cancer [EARLY_Phase 1]
An early-phase (Phase 1) trial of a targeted pathway inhibitor for pancreatic ductal adenocarcinoma is currently recruiting, enrolling patie…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating EDV Nanocell Therapy in combination with gemcitabine and nab-pacli…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for IN10018 in combination with RNK08954 for KRASG12D mutation-positive locally advanced or metastatic solid tumors; t…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate a combination therapy for localized pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of AZD5863 in adults with advanced or metastatic solid tumors is currently recruiting, including gastric cancer, gastroeso…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers [NA]
Clinical trial evaluating early multigene sequencing for theranostics in advanced cancers to guide therapy, across breast cancer, hepatocell…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC [NA]
This clinical trial update describes an early feasibility study evaluating YntraDose as a neoadjuvant treatment for locally advanced, unrese…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer [NA]
This clinical trial update notes a recruiting study evaluating a brief psychological intervention to improve emotional well-being during neo…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update details a biomarker-guided allogeneic CAR-NK cell therapy using single-target or dual-target constructs for advan…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures [NA]
A clinical trial is investigating personalized first-line chemotherapy choices for advanced pancreatic ductal adenocarcinoma using tumor tra…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations [Phase 2]
A Phase II nationwide, fully decentralized telemedicine study of pemigatinib for adults with FGFR-altered advanced or metastatic pancreatic …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer [NA]
Clinical trial update indicating ongoing recruitment for Nano-Megestrol Acetate to treat cancer cachexia in patients with advanced pancreati…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 [Phase 2]
Phase 2 clinical trial evaluating AZD0901 in advanced solid tumours expressing Claudin18.2 is currently recruiting, including gastric cancer…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
This is a Phase 2 clinical trial update of BXCL701 in combination with pembrolizumab for metastatic pancreatic ductal adenocarcinoma, with t…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial to evaluate the safety and efficacy of XER-001 (amifostine delivered nasoduodenally) in combination with stereotactic body…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating pegcetacoplan in combination with modified FOLFIRINOX for metastatic pancreatic ductal adenocarcinoma …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy [Phase 1]
This Phase 1 trial update seeks to identify a suitable dose of BI 765883 and to evaluate whether it benefits patients with advanced pancreat…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis [Phase 1]
A Phase 1 trial evaluating intraperitoneal paclitaxel in combination with the NALIRIFOX regimen for pancreatic ductal adenocarcinoma with pe…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study on Multimodal Prognostic Scoring of Advanced PDAC.
A clinical trial evaluating multimodal prognostic scoring for advanced pancreatic ductal adenocarcinoma is currently enrolling by invitation…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MK-2870 alone or with other therapies for gastrointestinal cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy [NA]
A clinical trial evaluating outcomes after laparoscopic versus open pancreaticoduodenectomy for pancreatic and periampullary cancers is curr…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer [NA]
This Boehringer Ingelheim-sponsored trial compares tissue and liquid biopsies across multiple cancers—non-small cell lung cancer, colorectal…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 [Phase 1]
Phase 1 study assessing adverse events and change in disease activity in adults with select advanced solid tumors treated with ABBV-400; the…